ArgusEye AB
PrivateLast Round
Early Funding
Apr 24, 2026
Total Funding Raised
$10.57M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ArgusEye AB operates in Healthcare & Life Sciences and is based in Linköping. Its latest recorded funding round was an Early Funding round in April 2026.
ArgusEye AB is a biotechnology company that develops nanoplasmonic biosensor solutions for real-time monitoring of biological systems and processes in the biopharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArgusEye AB Comparables
Compare ArgusEye AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck | 74% | |
| 908 Devices Inc. | 73% | |
| IDEX Corp | 73% |
For institutional investors. Book with your work email.
ArgusEye AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 24, 2026 | ||||
| Grant | Feb 18, 2026 | ||||
| Accelerator | Feb 18, 2026 | ||||
| Seed | May 13, 2024 | ||||
| Seed | Dec 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ArgusEye AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Accelerator |
| Almi Invest AB | Seed |
| Eir Ventures | Early Funding, Seed |
| Voima Ventures | Early Funding, Seed |
| Impilo | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 221% MoM, reaching 4.9K.
- Jun 23, 2026
Grew 19% QoQ, from 21 to 25 employees.
For institutional investors. Book with your work email.
ArgusEye AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ArgusEye AB's valuation, stock price, and market status.
Is ArgusEye AB a public or private company?
ArgusEye AB is a private company.
What is the current stock price of ArgusEye AB?
ArgusEye AB is a private company, so its shares have no public market price. Caplight tracks ArgusEye AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ArgusEye AB worth (valuation)?
Valuation information for ArgusEye AB is not publicly available.
Can I buy ArgusEye AB stock?
ArgusEye AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ArgusEye AB's last funding round?
ArgusEye AB's most recent funding round was Early Funding on April 24, 2026.
Who are the main investors in ArgusEye AB?
Key investors in ArgusEye AB include Almi Invest AB, Eir Ventures, Voima Ventures.
Will ArgusEye AB IPO soon?
No public IPO plans have been announced for ArgusEye AB.
How can I track ArgusEye AB secondary market activity?
Caplight tracks bids, offers, and trades in ArgusEye AB's shares on secondary markets.